Strategizing for Rapid Changeovers in Biologics Manufacturing

09.21.2020

Syed T. Husain, senior vice president and CDMO business unit head at Emergent BioSolutions recently contributed to an editorial titled, "Strategizing for Rapid Changeovers in Biologics Manufacturing" in the September issue of BioPharm International.

Read the full article here.

Article Details

BioPharm International
Vol. 33, No. 9
September 2020
Pages: 22–25, 50

Citation

C. Challener, “Strategizing for Rapid Changeovers in Biologics Manufacturing," BioPharm International, 33 (9) 2020.

Emergent CDMO

editorials Thought Leadership

04.27.2020

May 4th Webinar: Rapid Readiness for Pandemic Response

Watch our latest webinar on the topic of how drug developers can maximize capacity, capabilities and expertise for pandemic...

03.19.2020

Vaxart AGREEMENT for Experimental Oral Vaccine Candidate for Coronavirus Disease

GAITHERSBURG, Md.,March 18, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

10.27.2022

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...